Overview

Autologous Cell Therapy After Stroke

Status:
Withdrawn
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This study will examine the safety of two different cellular therapies in the treatment of stroke.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, Irvine
Collaborator:
University of California, San Diego